/
Dr  sanjena Dr  sanjena

Dr sanjena - PowerPoint Presentation

conchita-marotz
conchita-marotz . @conchita-marotz
Follow
410 views
Uploaded On 2016-02-28

Dr sanjena - PPT Presentation

Mithra fy1 ASTHMA AND COPD Objectives Differentiate severity of acute asthma exacerbations Pathophysiology of Asthma and COPD Discuss CXR and ABG Type 1 vs Type 2 respiratory failure ID: 235302

copd asthma salbutamol acute asthma copd acute salbutamol chronic abg respiratory type airway air severity chest mins inhaler failure

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Dr sanjena" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Dr sanjena Mithra, fy1

ASTHMA AND COPDSlide2

ObjectivesDifferentiate severity of acute asthma exacerbations

Pathophysiology

of Asthma and COPD

Discuss CXR and ABG

Type 1

vs

Type 2 respiratory failureSlide3

5 mins

pretest

10

mins

– case 1

10

mins

– case 2

5

mins

– end of session test

feedbackSlide4

PretestDefine asthma

What constitutes COPD?

Briefly outline the

pathophysiology

of asthma

Describe 4 differences in the airways of acute and chronic asthmatics.

How can you categorise severity of acute asthma attacks?

List 4 classes of drug used to treat Asthma/COPD

What are their mechanisms of action and side effects?

How can you determine severity of COPD?

Compare type 1 and type 2 respiratory failureSlide5

Take a history from this patient who is short of breath…

Cough +/- sputum

Chest pain (

pleuritic

)

Wheeze

SMOKING

Allergies, Pets

Foreign travel

History of DVT, PE*Compliance with meds*Weight lossHaemoptysis

Atopy

Family history

Exercise tolerance

Diurnal

variation

Complications:

Oedema

SOBOE

Recurrent infections

FeverSlide6

CASE 1- Summary

28 year old lady presents to A&E after becoming short of breath whilst visiting friends. She was feeling well during the day and had been to work. Non-smoker

PMH: Asthma since childhood –

Salbutamol

PRN

Inhaler currently not relieving symptoms; SOB worse over last 2 hours. Chest starting to feel tight, she is getting lightheaded.

On examination:

T 36.2 BP 124/71 HR 90 RR26 96%

sats

on airAlert, talking in full sentences but distressed. CVS and Abdo – NADResp – widespread wheeze, no crackles, no friction rubSlide7

What are your differentials for this patient and why?

Acute asthma exacerbation (non-life threatening)

PE

Inhaled foreign body

Allergic reaction

Anxiety

Pathophysiology

Define asthma

4 characteristics of acute and chronic asthmaSlide8

Asthma

ASTHMA –

chronic, inflammatory disease of the airways resulting in variable, often reversible airflow obstruction and airway

hyperresponsiveness

.

Acute asthma airway changes

-

Airway constriction,

microvascular

leakage / oedema, vasodilation, mucus hypersecretionIgE mediated inflammatory response. Cross-linking of IgE

results in

degranulation

of mast cells, histamine release and inflammatory cell infiltration

Chronic asthma

airway changes

– airway remodellingSubepithelial fibrosis, smooth muscle hyperplasia / hypertrophy, goblet cell hyperplasia, new vessel formationSlide9

Investigations

What investigations would you like to do?

Bedside:

Peak flow – 45% of best

Bloods:

ABG

, FBC, U&E, CRP

Imaging: CXR

ABG:

pH 7.46pCO2 4.1pO2 10.3HCO3 26

Respiratory Acidosis

Respiratory Alkalosis

Metabolic Acidosis

Metabolic Alkalosis

pH

pH

pH

pH

Primary problem:

pCO2

Primary problem:

pCO2

Primary problem:

HCO3

Primary problem:

HCO3

Compensation:

HCO3

Compensation

HCO3

Compensation:

pCO2

Compensation:

pCO2

↑Slide10

Reading Chest X-RaysRIP...ABCDE

Adequacy:

Rotation

(symmetry of clavicles)

Inspiration

(ribs)

Penetration

(vertebral bodies)

Mention central lines, NG tubes, pacemakers etc

Airway:

is the trachea central?

Boundaries and Both lungs:

lung borders, consolidation, hazy etc

Cardiac:

Heart size

Diaphragm

Everything else:

soft tissue mass, fracturesSlide11

What investigations would you like to do?

Bedside:

Peak flow – 45% of best

Bloods:

ABG

, FBC, U&E, CRP

Imaging: CXR

Allergic

bronchopulmonary

aspergillosis

: refractory asthma with fever, cough and sputum.

Eosinophilia

and raised

IgESlide12

Acute severe asthmaHow would you like to manage this patient?

Immediate

A to E

Salbutamol

5mg via oxygen driven nebuliser

Repeat

obs

(SpO2, HR, RR) and PEF to assess for progression of severity and risk to life

If clinically stable and PEF >75%, can repeat

Salbutamol nebs and consider oral prednisolone 40-50mgSlide13

Moderate

PEF >50-75%

SpO2 >92%

No features of severe

Acute Severe

PEF 33-50%

RR >25

SpO2 >92%

HR >110

Cannot complete sentences

Life threatening

33-92-CHEST

PEF <33%

SpO

2

<92%

Cyanosis/Confusion, Hypotension, Exhaustion, Silent chest, Tachycardia

Senior help (ITU, anaesthetics)

O SHIT!

O2 to maintain

sats

94-98%

Salbutamol

5mg via O2 driven nebs

Hydrocortisone IV/oral

prednisolone

Ipratropium

via O2 driven nebs

Consider Magnesium Sulphate IV

ABG, CXR

Salbutamol

4 puffs, then 2 puffs every 2

mins

Salbutamol

5mg via O2 driven nebuliser

If life threatening features present

Repeat

salbutamol

nebs, give oral

prednisolone

40-50mgSlide14

Long term managementLong term

Conservative: Follow up by GP, check inhaler technique, refer to chest clinic/asthma liaison nurse

Medical: If PEF <50% on admission, can consider

prednisolone

, adequate inhaler supply

Stepwise treatment of asthmaSlide15

CommunicationPlease explain to Mr X how to correctly use his inhaler

Check understanding

If you haven’t used it for a while, spray in the air to check it works

Shake it

As you breathe in, simultaneously press down on the inhaler

Continue to breathe deeply

Hold your breath for 10 seconds or as long as you comfortably can, before breathing out slowly.

If you need to take another puff, wait for 30 seconds, shake your inhaler again then repeat

Advise on using a spacerSlide16

Chronic Management of AsthmaSlide17

Case 2 – Summary

A 64 year old gentleman presents to A&E with increasing SOB over the last 3 days. This is associated with a cough productive of thick, green sputum.

Gets SOB normally after about 5-10

mins

walking on the flat

PMH: “asthma”

SH: 50 cigarettes a day for the past 40 years.

On examination he is alert but visibly SOB

T 37.7 RR 25 HR 110 O2

sats 89% on air, you notice he is using his accessory muscles to breathe. Resp: hyperinflated chest, diffuse coarse crepitations

, widespread wheeze, reduced air entry bilaterally

CVS: JVP raised, ankle oedema (non-pitting)

Abdo

SNTSlide18

Case 2Slide19

What are your differentials for this patient and why?

Acute infective exacerbation of COPD

Pneumonia

Cor

pulmonale

Bronchiectasis

Pathophysiology

Define COPD clinically

Histopathology?Pathophysiology?Slide20

Definitions

COPD

: Umbrella term encompassing chronic bronchitis (chronic cough and sputum production on most days for at least 3 months per year for 2 years) and emphysema (pathological diagnosis of permanent destructive enlargement of distal air spaces)

Chronic bronchitis

: airway narrowing due to bronchiole inflammation, mucosal oedema and mucus

hypersecretion

Emphysema

: Destruction and enlargement of alveoli that reduces elastic recoil and results in

bullae

.Slide21

Investigations

What investigations would you like to do?

Bedside: ECG, sputum culture

Bloods:

ABG

, FBC, U&E, CRP, blood cultures

Imaging: CXR

Special tests: ECHO,

α

1-antitrypsin levelsABG: assess the oxygenationChecking for respiratory failure- failure to fully oxygenate the blood passing through the lungs giving rise to hypoxia +/- hypercapnea.Slide22

ABG

pH 7.29

pCO2 6.8

pO2 7.9

HCO3 25Slide23

Respiratory failureType 1- hypoxia with low or normal pCO2 – anything that

impairs gas exchange

Atelectasis

, pulmonary oedema, pneumonia,

pneumothorax

Type 2 – hypoxia with hypercapnea –

alveolar hypoventilation

Same causes for a respiratory acidosis

COPD, neuromuscular disorders (GBS, MND), CNS depression (drugs, brainstem injuries) Slide24

Initial management – infective exacerbation of COPD

How would you like to manage this patient?

Immediate

A to E

Maintain

sats

88-92% (titrate to ABG)

Corticosteroids (oral/IV)

Empirical antibiotics

Salbutamol 5mg and Ipratropium via O2 driven nebulisersConsider need for NIV – if desaturating/decompensating

Admit, chest physiotherapySlide25

Flow volume loops - SpirometrySlide26

FEV1/FVCDetermines the severity of COPD

Describes the proportion of a person’s vital capacity (maximum air expelled after maximum inhalation) that can be expired in the first second.

Normal ~ 70%

Mild 50-70%

Moderate 30-50%

Severe <30%Slide27

Management Long term

Conservative – smoking cessation, pulmonary rehabilitation, flu vaccination,

Spirometry

Medical – LTOT (

only if not smoking

), bronchodilators, steroids (can consider if more than 2 infective exacerbations/year), prophylactic antibiotics

Surgical – Transplant,

lobectomy

,

bullectomyLTOT criteriaPaO2 <7.3 kPa on air during period of clinical stabilityPaO2 7.3-8.0

kPa

and signs of secondary

polycythaemia

, nocturnal

hypoxaemia

, peripheral oedema or pulmonary hypertensionSlide28

Drugs 1Bronchodilators:

Beta-2 agonists – Short acting/Long acting (Salbutamol/

Salmeterol

)

MOA: increases

cAMP

production in the lung which decreases calcium concentration

Effect: Smooth muscle relaxation, bronchial dilatation

S/e: tachycardia, sweating, tremor

Anticholinergics:Ipratropium (Atrovent), Tiotropium (Spiriva

)

MOA: Anti-

muscarinic

.

Ipratropium

is non-selective,

Tiotropium is selective (M3)s/e: dry mouth, sedation, skin flushing, tachycardiaSlide29

Drugs 2

Methyxanthines

Theophylline

,

Aminophylline

MOA:

Phosphodiesterase

antagonists – raise intracellular

cAMP

levels. Works well with beta-2 agonistss/e: narrow therapeutic windowLeukotriene receptor antagonists Montelukast,

Zafirlukast

s/e: GI upset, drowsiness

Corticosteroids

Prednisolone,

Beclamethosone

MOA:

upregulates intracellular proteins after binding with receptor and causes expression of anti-inflammatory agentss/e: weight gain, immunosuppression, skin thinning, bruising, osteoporosis, cataractsSlide30

PretestDefine asthma

What constitutes COPD?

Briefly outline the

pathophysiology

of asthma

Describe 4 differences in the airways of acute and chronic asthmatics.

How can you categorise severity of acute asthma attacks?

List 4 classes of drug used to treat Asthma/COPD

What are their mechanisms of action?

How can you determine severity of COPD?Compare type 1 and type 2 respiratory failureSlide31

Take home message33-92 CHEST

Focussed history taking: Symptoms, red flags, complications

Structure your answers

Questions?

Related Contents


Next Show more